Metrovacesa S.A.
Common Stock · EUR · BME
Price
€10.61
Cap
—
Earnings
—
30d Trend
-8.7%
37% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 58×Macro 0.99 (−1%)=57
RISK
QUALITY
MOMENTUM
TECHNICAL
REIT FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
Moderate long-term case — not compelling enough for a multi-year commitment
BRAIN47'S ASSESSMENT
I rate Metrovacesa S.A. at 57/100 — a STRONG reading on the Brain47 Signal. The strongest factor is momentum at 71/100. I classify this as a growth position with the strongest thesis on a long-term horizon.
PAST PERFORMANCE
1 MONTH
-2.6%
3 MONTHS
-11.6%
12 MONTHS
+18.5%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
Moderate long-term case — not compelling enough for a multi-year commitment. Momentum (71) and Fundamentals (59) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. Historical volatility is moderate at 37%. I classify this as a growth position — strong momentum combined with solid fundamentals points to capital appreciation.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.